NASDAQ : IPHA

Innate Pharma S.A. — Financial statements

Healthcare · Biotechnology · France

Last price 1.5 USD (Oct 30, 2026, 9:37 AM EDT) · Market cap 134.53M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Innate Pharma S.A. (IPHA) reported revenue of 9.81M EUR (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Operating Revenue4.23M2.79M12.62M51.90M49.58M12.11M
Other Revenue5.58M6.22M7.50M9.74M8.09M12.59M
Revenue9.81M9.01M20.12M61.64M57.67M24.70M
Cost of Revenue39.98M43.62M51.98M56.02M51.66M47.00M
Gross Profit-30.17M-34.62M-31.86M5.62M6.01M-22.30M
Selling, General & Admin17.42M19.39M19.72M18.29M22.44M25.52M
Operating Expenses17.42M19.39M19.72M18.29M22.44M25.52M
Operating Income-47.59M-54.01M-51.58M-12.67M-16.43M-47.83M
Interest Expense-381.00K-440.00K-566.00K-640.00K-288.00K-312.00K
Interest & Investment Income804.00K1.32M2.44M3.18M546.00K327.00K
Currency Exchange Gain (Loss)-662.00K3.20M-1.75M914.00K827.00K1.25M
Other Non Operating Income (Expenses)376.00K751.00K1.98M1.65M-1.63M1.08M
EBT Excluding Unusual Items-47.46M-49.18M-49.47M-7.57M-16.97M-45.48M
Asset Writedown-41.00M
Pretax Income-47.46M-49.18M-49.47M-7.57M-57.97M-45.48M
Earnings From Continuing Operations-47.46M-49.18M-49.47M-7.57M-57.97M-45.48M
Earnings From Discontinued Operations-131.00K-7.33M
Net Income-47.46M-49.18M-49.47M-7.57M-58.10M-52.81M
Net Income to Common-47.46M-49.18M-49.47M-7.57M-58.10M-52.81M
Shares Outstanding (Basic)93.04M89.59M81.05M80.45M79.64M79.54M
Shares Outstanding (Diluted)93.04M89.59M81.05M80.45M79.64M79.54M
EPS (Basic)-0.51-0.55-0.61-0.09-0.73-0.66
EPS (Diluted)-0.51-0.55-0.61-0.09-0.73-0.66
Free Cash Flow-42.81M-52.90M-7.29M-32.91M-19.69M-59.39M
Free Cash Flow Per Share-0.46-0.59-0.09-0.41-0.25-0.75
Gross Margin-158.34%9.12%10.42%-90.28%
Operating Margin-485.25%-599.77%-256.32%-20.55%-28.48%-193.60%
Profit Margin-483.85%-546.11%-245.87%-12.28%-100.74%-213.78%
Free Cash Flow Margin-436.45%-587.40%-36.22%-53.39%-34.14%-240.40%
EBITDA-46.96M-53.31M-50.27M-8.53M-12.02M-43.23M
EBITDA Margin-249.86%-13.84%-20.84%-174.99%
D&A For EBITDA631.00K700.00K1.30M4.14M4.41M4.60M
EBIT-47.59M-54.01M-51.58M-12.67M-16.43M-47.83M
EBIT Margin-256.32%-20.55%-28.48%-193.60%
Revenue as Reported9.81M9.01M20.12M61.64M57.67M24.70M

Balance sheet

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents6.46M28.09M66.40M70.61M84.22M103.76M
Short-Term Investments4.43M6.22M14.37M21.85M17.26M16.08M
Cash & Short-Term Investments10.90M34.31M80.77M92.46M101.48M119.84M
Accounts Receivable260.00K391.00K650.00K15.23M3.08M846.00K
Other Receivables4.33M7.22M993.00K31.26M27.94M12.63M
Receivables4.59M7.61M1.64M46.49M31.02M13.47M
Prepaid Expenses1.86M2.39M2.82M5.69M4.67M2.58M
Other Current Assets2.26M2.40M509.00K3.37M2.65M2.36M
Total Current Assets19.60M46.71M85.74M148.01M139.83M138.26M
Property, Plant & Equipment3.64M4.36M5.13M6.32M8.54M10.17M
Long-Term Investments10.48M10.46M10.28M9.80M35.12M39.88M
Other Intangible Assets416.00K1.56M44.19M
Long-Term Deferred Tax Assets5.03M
Other Long-Term Assets1.00M1.20M9.90M10.64M14.25M29.97M
Total Assets34.73M62.72M111.06M175.19M199.29M267.50M
Accounts Payable5.43M7.47M7.92M8.56M13.66M14.73M
Current Portion of Long-Term Debt10.70M8.52M8.44M8.45M1.28M29.94M
Current Portion of Leases90.00K287.00K271.00K485.00K824.00K804.00K
Current Income Taxes Payable5.14M6.55M6.96M7.02M5.98M7.46M
Current Unearned Revenue9.12M9.33M8.06M13.51M16.78M19.92M
Other Current Liabilities2.37M4.50M1.33M1.61M2.82M7.03M
Total Current Liabilities32.86M36.65M32.98M39.64M41.34M79.89M
Long-Term Debt9.37M13.67M22.18M30.61M38.93M11.49M
Long-Term Leases44.00K97.00K104.00K350.00K1.22M2.01M
Long-Term Unearned Revenue30.62M31.75M43.95M49.65M60.91M58.41M
Pension & Post-Retirement Benefits1.95M1.92M2.73M2.44M2.55M2.98M
Long-Term Deferred Tax Liabilities5.03M
Other Long-Term Liabilities395.00K332.00K274.00K604.00K198.00K254.00K
Total Liabilities75.23M84.42M102.22M123.29M145.14M160.06M
Common Stock4.70M4.69M4.19M4.04M4.01M3.98M
Additional Paid-In Capital409.09M408.03M390.98M384.25M379.64M375.22M
Retained Earnings-455.16M-435.54M-386.36M-336.89M-330.32M-272.21M
Comprehensive Income & Other865.00K1.12M27.00K495.00K819.00K455.00K
Shareholders' Equity-40.51M-21.70M8.83M51.90M54.15M107.44M
Total Liabilities & Equity34.73M62.72M111.06M175.19M199.29M267.50M
Total Debt20.21M22.57M31.00M39.89M42.25M44.25M
Net Cash (Debt)-9.31M11.74M49.77M52.56M59.23M75.58M
Net Cash Per Share-0.100.130.610.650.740.95
Filing Date Shares Outstanding93.70M93.79M92.16M80.86M80.19M79.54M
Total Common Shares Outstanding93.70M93.70M83.83M80.86M80.19M79.54M
Working Capital-13.26M10.06M52.76M108.38M98.49M58.37M
Book Value Per Share-0.43-0.230.110.640.681.35
Tangible Book Value-40.51M-21.70M8.83M51.48M52.59M63.25M
Tangible Book Value Per Share-0.43-0.230.110.640.660.80

Cash flow statement

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-47.46M-49.18M-49.47M-7.57M-58.10M-52.81M
Depreciation & Amortization1.29M1.38M1.99M5.09M4.41M4.60M
Loss (Gain) From Sale of Assets196.00K23.00K20.00K-521.00K-367.00K
Asset Writedown & Restructuring Costs41.00M
Loss (Gain) From Sale of Investments-292.00K-451.00K-1.33M-1.59M1.37M-987.00K
Stock-Based Compensation2.08M2.57M3.94M4.26M4.25M2.62M
Other Operating Activities-780.00K3.53M-1.21M-131.00K425.00K-1.62M
Change in Accounts Receivable8.23M1.65M51.81M
Change in Accounts Payable-772.00K-965.00K-1.01M
Change in Unearned Revenue-3.06M-616.00K-7.04M
Change in Other Net Operating Assets-1.69M-10.32M-4.11M-32.09M-12.50M-9.88M
Operating Cash Flow-42.63M-52.76M-6.90M-32.56M-19.16M-58.46M
Capital Expenditures-172.00K-140.00K-391.00K-351.00K-535.00K-929.00K
Sale of Property, Plant & Equipment150.00K7.00K
Sale (Purchase) of Intangibles-2.00M-587.00K-401.00K
Investment in Securities2.01M7.04M9.59M22.77M3.00M
Other Investing Activities505.00K394.00K1.00K63.00K-1.00K406.00K
Investing Cash Flow2.35M7.29M9.20M20.63M1.88M-917.00K
Long-Term Debt Issued28.70M
Long-Term Debt Repaid-8.91M-8.94M-2.36M-2.03M-2.07M
Net Debt Issued (Repaid)-6.82M-8.91M-8.94M-2.36M-2.03M26.63M
Issuance of Common Stock49.00K14.98M2.93M395.00K198.00K499.00K
Other Financing Activities-311.00K
Financing Cash Flow-6.77M6.07M-6.01M-1.97M-1.83M26.82M
Foreign Exchange Rate Adjustments-183.00K1.09M-505.00K274.00K-428.00K-483.00K
Miscellaneous Cash Flow Adjustments1.00K3.00K-1.00K
Net Cash Flow-47.24M-38.30M-4.21M-13.62M-19.53M-33.04M
Free Cash Flow-42.81M-52.90M-7.29M-32.91M-19.69M-59.39M
Free Cash Flow Margin-436.45%-587.40%-36.22%-53.39%-34.14%-240.40%
Free Cash Flow Per Share-0.46-0.59-0.09-0.41-0.25-0.75
Levered Free Cash Flow-28.96M-34.07M17.12M-27.07M-32.74M-15.02M
Unlevered Free Cash Flow-28.72M-33.80M17.47M-26.67M-32.56M-14.82M
Cash Interest Paid312.00K
Change in Working Capital2.33M-10.63M39.16M-32.09M-12.50M-9.88M

Ratios

Fiscal year January - December; amounts in EUR.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization131.41M173.38M165.58M233.49M281.97M399.94M
Enterprise Value141.80M134.64M107.30M180.18M196.50M283.01M
Last Close Price1.461.751.842.803.734.56
PS Ratio11.7316.407.953.434.5814.24
PB Ratio-6.8018.114.074.873.27
P/TBV Ratio18.114.105.025.56
EV/Sales Ratio12.6512.735.152.653.1910.07
Debt / Equity Ratio-0.50-1.043.510.770.780.41
Net Debt / Equity Ratio-0.230.54-5.63-1.01-1.09-0.70
Net Debt / EBITDA Ratio-0.200.220.996.164.931.75
Net Debt / FCF Ratio-0.220.226.831.603.011.27
Asset Turnover0.150.100.140.330.250.09
Quick Ratio0.471.142.503.513.211.67
Current Ratio0.601.272.603.733.381.73
Return on Equity (ROE)-162.91%-14.28%-71.75%-34.53%
Return on Assets (ROA)-46.60%-38.85%-22.52%-4.23%-4.40%-10.40%
Return on Invested Capital (ROIC)-2,545.08%-207.17%-173.03%
Return on Capital Employed (ROCE)-2,545.10%-207.20%-66.10%-9.30%-10.40%-25.50%
Earnings Yield-39.12%-33.30%-30.93%-3.58%-22.02%-15.02%
FCF Yield-36.48%-35.82%-4.56%-15.58%-7.46%-16.89%
Buyback Yield / Dilution-10.65%-10.54%-0.74%-1.02%-0.12%-0.77%